Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Wuxi Biologics (Cayman) (1FW2) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1FW2Wuxi Biologics (Cayman)EUR 5.45EUR 22.37B32.8344.10%Strong BuyUnlock the DE:1FW2 analyst price target with TipRanks PremiumDE:1FW2Unlock the DE:1FW2 top-analyst price target with TipRanks Premium
HK:1548Genscript BiotechHKD 30.38HKD 69.04B-12.9784.01%Strong BuyUnlock the HK:1548 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1548Unlock the HK:1548 top-analyst price target with TipRanks Premium
HK:3759Pharmaron Beijing Co., Ltd. Class HHKD 28.10HKD 82.53B42.8616.40%Strong BuyUnlock the HK:3759 analyst price target with TipRanks PremiumDE:1FW2 vs HK:3759Unlock the HK:3759 top-analyst price target with TipRanks Premium
HK:1521Frontage Holdings Corp.HKD 2.08HKD 4.23B50.8690.37%―Unlock the HK:1521 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1521Unlock the HK:1521 top-analyst price target with TipRanks Premium
HK:1873Viva Biotech HoldingsHKD 1.26HKD 2.62B13.04-42.20%―Unlock the HK:1873 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1873Unlock the HK:1873 top-analyst price target with TipRanks Premium
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class HHKD 41.40HKD 18.40B41.3927.38%―Unlock the HK:2315 analyst price target with TipRanks PremiumDE:1FW2 vs HK:2315Unlock the HK:2315 top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1FW2Wuxi Biologics (Cayman)5.451.8651.81%
HK:1548Genscript Biotech30.3813.3878.71%
HK:3759Pharmaron Beijing Co., Ltd. Class H28.106.0327.32%
HK:1521Frontage Holdings Corp.2.081.0193.93%
HK:1873Viva Biotech Holdings1.26-0.81-39.13%
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H41.407.8223.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts